The global proton therapy market was valued at $438.33 million in 2021, and is projected to reach $1579.39 million by 2031, registering a CAGR of 13.65% from 2022 to 2031.
Proton therapy is the most precise and advanced type of radiation therapy. It is widely used to treat cancer. It has a number of advantages over traditional radiation therapy, in terms of efficacy and adverse effects. It is a pleasant, non-invasive treatment that helps patients retain their quality of life and return to normal activities fast. It enables doctors to administer full or greater treatment dosages that kill primary tumors without harming healthy tissues or organs. Major limitations of photon therapy or other particle therapies are overcome by proton therapy. Advancements in technology have increased adoption of proton therapy for treatments of various cancers across the globe.
Demand for proton therapy is anticipated to increase globally during the forecast period, owing to increase in prevalence of cancer and surge in number of awareness campaigns about benefits of proton therapy and technological advancements in radiotherapy devices. Moreover, patients are eager to know more about proton therapy treatment process and increase in recognition of proton therapy drive growth of the market, globally. However, higher cost of proton therapy is anticipated to hamper the market growth. In addition, proton therapy devices are very large in size and require large space with dedicated areas. The setup cost is exclusive of the device cost, which further increases investments, thereby restraining growth of this market. Moreover, introduction of proton therapy in emerging economies is expected to offer lucrative growth opportunities for key players in the market.
The global proton therapy market is segmented into indications, product type, end user, and region. By indication, the market is divided into head & neck cancer, central nervous system cancer, prostate cancer, breast cancer, and others. According to product type, it is bifurcated into accelerator, beam transport system, beam delivery system, nozzles & image viewers, and patient positioning system. On the basis of end user market, it is divided into hospitals, proton therapy centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Major companies profiled in the report include Hitachi, Ltd., Ion Beam Applications S.A., Mevion Medical Systems, Mirion Technologies Ltd., Optivus Proton Therapy, Inc., Provision Healthcare, Pro Tom International, Siemens, Sumitomo Heavy Industries, Ltd., and Toshiba Corporation.
Geographical analysis of the market is expected to help companies to plan their strategies accordingly and take region specific decisions.
Analysis of key strategies adopted by market players is expected to provide market intelligence and help stakeholders understand competitive structure of the market.
The report analyzes market conditions in a comprehensive and quantitative manner and forecasts market trends and techniques for proton therapy applications.
Proton therapy is the most precise and advanced type of radiation therapy. It is widely used to treat cancer. It has a number of advantages over traditional radiation therapy, in terms of efficacy and adverse effects. It is a pleasant, non-invasive treatment that helps patients retain their quality of life and return to normal activities fast. It enables doctors to administer full or greater treatment dosages that kill primary tumors without harming healthy tissues or organs. Major limitations of photon therapy or other particle therapies are overcome by proton therapy. Advancements in technology have increased adoption of proton therapy for treatments of various cancers across the globe.
Demand for proton therapy is anticipated to increase globally during the forecast period, owing to increase in prevalence of cancer and surge in number of awareness campaigns about benefits of proton therapy and technological advancements in radiotherapy devices. Moreover, patients are eager to know more about proton therapy treatment process and increase in recognition of proton therapy drive growth of the market, globally. However, higher cost of proton therapy is anticipated to hamper the market growth. In addition, proton therapy devices are very large in size and require large space with dedicated areas. The setup cost is exclusive of the device cost, which further increases investments, thereby restraining growth of this market. Moreover, introduction of proton therapy in emerging economies is expected to offer lucrative growth opportunities for key players in the market.
The global proton therapy market is segmented into indications, product type, end user, and region. By indication, the market is divided into head & neck cancer, central nervous system cancer, prostate cancer, breast cancer, and others. According to product type, it is bifurcated into accelerator, beam transport system, beam delivery system, nozzles & image viewers, and patient positioning system. On the basis of end user market, it is divided into hospitals, proton therapy centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Major companies profiled in the report include Hitachi, Ltd., Ion Beam Applications S.A., Mevion Medical Systems, Mirion Technologies Ltd., Optivus Proton Therapy, Inc., Provision Healthcare, Pro Tom International, Siemens, Sumitomo Heavy Industries, Ltd., and Toshiba Corporation.
KEY BENEFITS FOR STAKEHOLDERS
This report provides an in-depth analysis of the proton therapy market with current trends and estimations from 2022 to 2031.Geographical analysis of the market is expected to help companies to plan their strategies accordingly and take region specific decisions.
Analysis of key strategies adopted by market players is expected to provide market intelligence and help stakeholders understand competitive structure of the market.
The report analyzes market conditions in a comprehensive and quantitative manner and forecasts market trends and techniques for proton therapy applications.
Key Market Segments
By Indication
- Head and Neck Cancer
- CNS Cancer
- Prostate Cancer
- Breast Cancer
- Others
By Product Type
- Accelerator
- Beam Transport System
- Beam Delivery System
- Nozzle and Image Viewers
- Patient Positioning System
By End User
- Hospitals
- Proton Therapy Centers
- Others
By Region
- North America
- U.S.
- Europe
- Germany
- France
- U.K.
- Rest of Europe
- Asia-Pacific
- Japan
- China
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Saudi Arabia
Key Market Players
- ION BEAM APPLICATIONS
- Provision Healthcare
- HITACHI LTD.
- MEVION MEDICAL SYSTEMS
- OPTIVUS PROTON THERAPY INC.
- PRONOVA SOLUTIONS LLC.
- SUMITOMO CORPORATION
- Siemens Ltd
- Mirion Technologies
- Toshiba Corp.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: PROTON THERAPY MARKET, BY INDICATION
CHAPTER 5: PROTON THERAPY MARKET, BY PRODUCT TYPE
CHAPTER 6: PROTON THERAPY MARKET, BY END USER
CHAPTER 7: PROTON THERAPY MARKET, BY REGION
CHAPTER 8: COMPANY LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report, titled, “Proton Therapy Market," the proton therapy market size was $438.33 million in 2021, and is estimated to reach $1.6 billion by 2031, growing at a CAGR of 13.65% from 2022 to 2031.Proton therapy, also known as proton radiotherapy and proton beam therapy, involves radiation devices with protons as a source of radiation. Proton therapy is used to kill cancer cells. In proton therapy particle accelerators are used to target the tumors with a beam of protons. Protons are charged particles that interfere with DNA of cells, thus damaging them leading to cell death. Proton therapy devices are costly, space consuming equipment that comprises accelerators, electro-magnets, gantries, nozzles, and patient rooms.
Increase in prevalence of cancer, surge in number of awareness campaigns about benefits of proton therapy, and technological advancements in proton therapy devices are the key proton therapy market trends. In addition, patients are eager to know more about proton therapy treatment process and growth of global recognition of proton therapy and its benefits further drive the market growth. However, high cost of proton therapy and large size of these devices, requiring dedicated areas, are anticipated to hamper the market growth. Conversely, introduction of proton therapy in emerging economies is expected to offer lucrative growth opportunities for key players in the market.
On the basis of indications, the proton therapy market is categorized into head & neck cancer, central nervous system cancer, prostate cancer, breast cancer and others. The central nervous system cancer segment is expected to dominate the market during the forecast period, owing to increase in prevalence of CNS cancer and rise in preference for advance therapies by healthcare professionals.
Depending on product type, the accelerator segment dominated the market in 2021, and is expected to remain dominant during the forecast period, owing to increase in prevalence of cancer, cost advantage as compared to outsourced radioactive tracers and availability of technologically advanced diagnostic devices further boost proton therapy market growth.
On the basis of end user, the hospital segment held the largest proton therapy market share in 2021, and is expected to continue this trend during the forecast period, owing to increase in prevalence of cancer, development in healthcare for infrastructure of hospitals, high tech equipment, and self-awareness about diseases.
North America accounted for the largest market share in 2021, and is expected to remain dominant during the forecast period. This was attributed to well-established healthcare system, increase in number of geriatric patients, and supportive reimbursement policies in healthcare system and increase in number of healthcare facilities offering proton therapy. Asia-Pacific is projected to register the highest CAGR of 14.95% during the forecast period. Improving healthcare infrastructure in the region and large patient populations for target diseases. In addition, expanding presence of key market players in the region propel the market growth.
Major companies profiled in proton therapy industry report include Hitachi, Ltd., Ion Beam Applications S.A., Mevion Medical Systems, Mirion Technologies Ltd., Optivus Proton Therapy, Inc., Provision Healthcare, Pro Tom International, Siemens, Sumitomo Heavy Industries, Ltd., and Toshiba Corporation.
Key Findings of the Study
- On the basis of indication, the CNS cancer segment is estimated to register CAGR of 12.41% from 2022 to 2031.
- On the basis of product type, the accelerator segment is estimated to register CAGR of 13.21% from 2022 to 2031.
- By end user, the hospital segment is anticipated to register CAGR of 13.8% from 2022-2031
- By region, Asia-Pacific is expected grow at the highest CAGR of 14.95% from 2022 to 2031.
Companies Mentioned
- Ion Beam Applications
- Provision Healthcare
- Hitachi Ltd.
- Mevion Medical Systems
- Optivus Proton Therapy Inc.
- Pronova Solutions LLC.
- Sumitomo Corporation
- Siemens Ltd
- Mirion Technologies
- Toshiba Corp.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | June 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 438.33 million |
| Forecasted Market Value ( USD | $ 1579.39 million |
| Compound Annual Growth Rate | 13.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
